Sorafenib From Palliative to Neoadjuvant Chemotherapy in Hepatocellular Carcinoma With Major Vascular Invasion: Experience of Two Cases

Hepatoma Research
doi 10.20517/2394-5079.2016.14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OAE Publishing Inc.

Related search

Two Nomograms to Select Hepatocellular Carcinoma Patients With Macroscopic Vascular Invasion for Hepatic Resection

Journal of Cancer
Oncology
2018English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Response to a Preoperative Single Intraarterial Chemotherapy Predicts Cancer Outcome After Liver Resection for Hepatocellular Carcinoma With Vascular Invasion

HPB
HepatologyGastroenterology
2016English

Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?

Hepatology
MedicineHepatology
2018English

Sorafenib-Induced Acute Interstitial Pneumonia in Patients With Advanced Hepatocellular Carcinoma: Report of Three Cases

Clinical Journal of Gastroenterology
MedicineGastroenterology
2012English

Sorafenib vs Nivolumab in Patients With Hepatocellular Carcinoma

Journal of Liver Research, Disorders & Therapy
2017English

Two Autopsy Cases of Hepatocellular Carcinoma With Hypoglycemic Attack

Acta Hepatologica Japonica
Hepatology
1976English

EP29.02: Superb Micro-Vascular Imaging in Cervical Carcinoma: Monitoring Treatment Response to Neoadjuvant Chemotherapy

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2017English

Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined With Sorafenib in Hepatocellular Carcinoma Showing Macrovascular Invasion

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy